No Data
BOCI International: Three Key Technologies Drive Growth; Positive Outlook for Brain-Computer Interface Industry's Potential Expansion
Since 2026, financing activities for brain-computer interface enterprises have remained robust, with companies such as Qiangnao Technology and Jieti Medical securing substantial funding. The influx of capital is accelerating the industrialization of brain-computer interface technologies.
Company Q&A | Mailande: The company's non-invasive brain-computer interface product is currently in the market promotion stage and has not yet obtained a medical insurance code.
On April 20, a user inquired on an interactive platform whether Mailande's brain-computer interface products had obtained a medical insurance code as an innovative product. Mailande responded that its non-invasive brain-computer interface products are currently in the market promotion phase and have not yet received a medical insurance code. The company consistently prioritizes research and development as well as industrial implementation of brain-computer interface technology, while closely monitoring national and regional medical insurance support policies for innovative medical devices.
Comment on Malande's (688273) 2025 Annual Report and 2026 Q1 Report: Steady Growth in Reproductive Rehabilitation Products; Innovative Breakthroughs in Brain-Computer Interface Technology
Event: 1) The company released its 2025 annual report, achieving operating revenue, net profit attributable to shareholders, and non-recurring net profit attributable to shareholders of RMB 432 million, RMB 103 million, and RMB 80 million respectively, representing year-on-year changes of +1.66%, +1.03%, and -1.98%.
Mailande's revenue in 2025 reached 432 million yuan, a slight increase of 1.66%, while its non-GAAP net profit amounted to 80.3825 million yuan, marking a decline of 1.98%.
The sales expense ratio exceeds 20%, R&D investment has increased to 15.31%, but the number of R&D personnel has decreased.
Mailande: First Quarter Report for 2026
Mailande: 2025 Annual Report